Skin substitutes come in wide range of categories. This, combined with their high cost and reimbursement requirements, can make selection challenging. Clinicians need to determine which skin substitute(s) in the range available are clinically effective and cost-effective for each individual patient’s needs.


In this masterclass, a select group of KOLs debated how to make good selection decisions, and quizzed manufacturers and suppliers as to when and why they should use their products.

The Masterclass, with its high-calibre debate and live Q&As, empowers clinicians to optimise patient outcomes and manage reimbursement issues effectively when using skin substitutes.

Programme

7:30 PM - 8:00 PM
Clinical debate
8:00 PM - 8:20 PM
Live Q&A
8:20 PM - 8:50 PM
Industry Presentations
8:50 PM - 9:30 PM
Second Live Q&A

MEET OUR SPEAKERS

Baljit Dheansa

Queen Victoria Hospital, East Grinstead

Consultant Plastic Surgeon

Dr. Paul Glat

Plastic and Reconstructive Surgeon

Dr. Robert Kirsner

University of Miami

Professor

Steven Jeffery

Consultant Burns and Plastic Surgeon

Dr. Thomas E. Serena

The SerenaGroup®

Founder and Medical Director

Meet our Sponsors



Cook Biotech is dedicated to providing advanced tissue-repair products for improving patient outcomes globally.

Products are manufactured using proprietary extracellular matrix (ECM) technologies and manufacturing processes.

Through collaboration with partners and distributors, Cook Biotech products are available globally under several brand names, including Vim™, Biodesign® and OASIS®.

Applications for ECM technology continually evolve. Together with a global network of scientists, partners, and medical practitioners, we continue to identify medical needs most compatible with ECM technology and develop products to meet those needs.

Cook Biotech is located in West Lafayette, Indiana, USA, and is a sister company to Cook Medical of Bloomington, Indiana. Learn more about Cook Biotech at cookbiotech.com and cookbiotech.eu.



Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and infection control markets.

The Kerecis fatty-acid-rich intact fish skin protects the body’s tissues and enables it to regenerate tissues. The Kerecis sprayable fatty-acid topical and oral formulations protect the body from bacterial and viral infections.

Our products are being used to treat wounds, burns and other complex acute and chronic wounds including diabetic, venous, trauma, and surgical wounds. Thousands of patients of all incomes, cultures and races have benefited from treatment with Kerecis.

Our fish skin comes from wild Atlantic cod, caught from a sustainable fish stock in pristine Icelandic waters and processed using renewable energy.


MiMedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary Purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over two million allografts, through both direct and consignment shipments.

For additional information, please visit www.mimedx.com.


The Spincare Wound Care System - Changing lives, not dressings

Nanomedic’s portable, handheld Spincare system is a fully personalized system, coupled with a ‎disposable, single patient polymer-based sterile solution ampule enables faster and pain-reduced ‎healing through real-time printing of a site-specific nanofibrous matrix directly onto a wound. ‎Spincare utilizes proprietary Electrospun Healing Fiber (EHF™) technology to treat even the most ‎‎severe and complicated wounds with a single application, eliminating the need for painful re-‎dressings. It solves both the short-term and long-term healing challenges.



Organisers

Subscribe to the Journal of Wound Care today! The leading monthly journal for nurses, medics and researchers working in wound care.

JWC is essential reading for wound care professionals who are serious about providing the best possible support for the people in their care, and those who want to keep on top of the latest thinking and research.

Contact Us

Anthony Kerr

Managing Director, MA Healthcare Ltd.

anthony.kerr@markallengroup.com

+44 (0) 207 501 6726

Emma Blick

Commercial Manager

emma.blick@markallengroup.com

+447584275545

Tracy Cowan

Associate Publisher, Projects Programme Planner

tracy.cowan@markallengroup.com

+44 (0) 207 501 6717

Events team

General enquiries

nurseledconferences@markallengroup.com

Watch NOW